CoChat

The Hypoxia-Inducible Factor 2 α N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo

Open access
Yan, Qin, Bartz, Steven, Mao, Mao, Li, Lianjie, Kaelin, William G. · 2007 · Molecular and Cellular Biology

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor, consisting of an alpha subunit and a beta subunit, that controls cellular responses to hypoxia. HIFalpha contains two transcriptional activation domains called the N-terminal transactivation domain (NTAD) and the C-terminal transactivation domain (CTAD). HIFalpha is destabilized by prolyl hydroxylation catalyzed by EglN family members. In addition, CTAD function is inhibited by asparagine hydroxylation catalyzed by FIH1. Both hydroxylation reactions are linked to oxygen availability. The von Hippel-Lindau tumor suppressor protein (pVHL) is frequently mutated in kidney cancer and is part of the ubiquitin ligase complex that targets prolyl hydroxylated HIFalpha for destruction. Recent studies suggest that HIF2alpha plays an especially important role in promoting tumor formation by pVHL-defective renal carcinoma cells among the three HIFalpha paralogs. Here we dissected the relative contribution of the two HIF2alpha transactivation domains to hypoxic gene activation and renal carcinogenesis and investigated the regulation of the HIF2alpha CTAD by FIH1. We found that the HIF2alpha NTAD is capable of activating both artificial and naturally occurring HIF-responsive promoters in the absence of the CTAD. Moreover, we found that the HIF2alpha CTAD, in contrast to the HIF1alpha CTAD, is relatively resistant to the inhibitory effects of FIH1 under normoxic conditions and that, perhaps as a result, both the NTAD and CTAD cooperate to promote renal carcinogenesis in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1128/mcb.01514-06

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Cited by

Metadata

Authors
Yan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G.
Affiliations
  • Brigham and Women's Hospital (US)
  • Rosetta Inpharmatics, LLC.
Corresponding author
Kaelin, William G.
Venue
Molecular and Cellular Biology
Published
2007-03-01
Volume
27
Issue
6
Pages
2092-2102
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2161071327
Cited by
193
References
58
Citations by year
2026: 5 · 2025: 8 · 2024: 5 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 14 · 2019: 19 · 2018: 6 · 2017: 9 · 2016: 12 · 2015: 7 · 2014: 11 · 2013: 14 · 2012: 9
FWCI
3.42
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • Dana-Farber/Harvard Cancer Center
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
HIF-2α, hypoxia-inducible factor, N-terminal transactivation domain, C-terminal transactivation domain, renal carcinogenesis, kidney cancer, VHL, prolyl hydroxylation, transcriptional activation, hypoxia
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Amino Acid Sequence, Animals, Cell Line, Cell Transformation, Neoplastic, Humans, Kidney Neoplasms, Mice, Nude, Molecular Sequence Data, Mutation, Transcriptional Activation, Sequence Alignment, Conserved Sequence, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, Rats, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.